During a quarterly conference call, as Apellis Pharmaceuticals discussed its plan to increase sales of GA treatment Syfovre, it stressed the importance of attracting more patients to the market, including through a DTC campaign starring Henry Winkler. More: Apellis warns
read moreOnce again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. More: Lilly promotes ‘healthy skepticism’ toward compounded drugs in new Oscars ad campaign Source: fierce
read moreRare Disease Day 2025 triggered a flurry of pharma marketing activity, with Arrowhead Pharmaceuticals, Zevra Therapeutics and a clutch of other drug developers publishing materials to mark the event. More: Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025
read moreEurope’s Committee for Medicinal Products for Human Use recommended four new drugs for approval, teed up another 16 potential label expansions and—in a major win for Eisai and Biogen—reaffirmed the positive opinion on the Alzheimer’s disease drug Leqembi it first
read moreFor GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed that she took a 16% pay cut in 2024, it also laid out a new compensation plan which could make
read moreOn Monday, Delaware’s state investment board approved a $30.2 million grant to Merck & Co., contingent on the company’s decision to set up operations at the Chestnut Run Innovation and Science Park outside the city of Wilmington. The “commercialization and
read more© 1994 - 2025 B.M. Pharmaceuticals